MSFT is on Ben’s radar. Here’s his plan...

Good morning trader! Here are some hump-day trade ideas you’d be interested in;  Focus List ⚡️ 👉 MyMD Pharmaceuticals, Inc. (MYMD)* — a clinical-stage pharmaceutical company that develops drug products targeting aging, age-related, and autoimmune diseases. 👉 S&P 500 ETF Trust (SPY) 👉 The giant tech corporation — Microsoft (MSFT) *This is an Issuer-Paid Advertisement, See Disclosure Below  FOMO: Still Missing The Action In The Chat Room? Quick reminder — four expert traders will be live in the 360 Chat Room throughout today, teaching… …and sharing hot trade ideas like this (AMC call options from Monday) — LIVE! No gimmicks, just pure value at no cost! [Click here to access the 360 Wallstreet chat room](  Sponsored by MYMD* Spotlight Stock 🔍 MYMD finally reached a critical high of $6 — the first time it has touched this level since the beginning of the year! If you’ve been following our updates, you probably know the stock has been on an upward trend since late June, and after a minor consolidation it has resumed that momentum. In case you didn’t notice, MYMD has rallied an impressive 40% in the last 5 days. Half of that move happened on Monday following [an analyst mentioning the stock on Fox Business News](. It has been an impressive move for sure, but what should you keep an eye on from here? How about the Relative Strength Index? This is an indicator from 0 and 100 and is helpful in determining the strength of a trend. RSI readings below 30 typically indicate the stock is oversold, while readings above 70 hint at overbought conditions. Right now the RSI(14) on the MYMD daily chart reads 73, just touching into overbought territory. But make no mistake! An RSI over 70 does NOT always provide a signal to sell when a stock is overbought. It may just mean the price is strong — that there were more bullish candles than bearish candles. There are many times a stock stays in “overbought” condition for longer than most people expect. When we combine this indicator with the simple moving averages, a clearer picture of the expected trend direction pops up. MYMD is still currently trading above the short (50-day) and long-term (200-day) moving average, which is a bullish indicator that a key resistance level may have been broken. But an important thing to look out for is a crossover of these two moving averages. When the short-term moving average crosses over the longer-term moving average, that’s typically a solid signal of strengthening momentum. The 50-day MA (red line) seems to be approaching the 200-day MA line. When it catches up — which we believe it will — there’s a good chance it may cross over on top. Bottom line is that MYMD has been on a tear lately, trading green on 9 out of the last 10 days! The upcoming catalysts and earnings date next week makes it all the more interesting. I’d keep an eye on this stock if I were you. *This is an Issuer-Paid Advertisement, See Disclosure Below  The Hotlist 🔥 Ben has MSFT on his radar and is waiting to see if the stock can get back above $286. He says he likes the $290 calls for next week with a target of $295. The stop would be somewhere below $284.  Davis’ SPY Trade Looks like SPY is within limited trading range again and holding its weekly 100-day Moving Average support level. With the 60-minute stochastics being bullish, Davis will plan to the upside today. He says he’ll trade with real money IF SPY gets above $413 or below the $412 level — otherwise, it’s not worth the reward-to-risk. If SPY gets above $413, he’ll be looking for a 3 / 8 EMA crossover to the upside above VWAP to trade SPY Calls, targeting a move to about $414. If SPY breaks below $412, Davis will look for a 3 / 8 EMA crossover to the downside below VWAP to trade SPY Puts, targeting a move toward yesterday’s closing price support.  62 Calef Hwy #233 Lee, New Hampshire 03861 United States Questions or concerns about our products? Email Support@ragingbull.com  © Copyright 2022, RagingBull - Refund Policy - Privacy Policy - Terms & Conditions  *THIS IS AN ISSUER-PAID ADVERTISEMENT, SEE DISCLOSURE BELOW*ISSUER-PAID ADVERTISEMENT. MyMD, Inc. (“MYMD” or the “Company”) HAS PAID ORWILL PAY SHERWOOD VENTURES, LLC (“Sherwood”) TWENTY-THOUSAND DOLLARS USD PER MONTH FOR THREE MONTHS (THE “INITIAL TERM”) IN CASH, SHARES OF RESTRICTED COMMON STOCK WITH A VALUE OF ONE-HUNDRED-FIFTY THOUSAND DOLLARS, AND WARRANTS VALUED AT ISSUANCE OF SEVENTY-FIVE THOUSAND DOLLARS FOR MARKETING SERVICES INCLUDING COMMUNICATING TO THE PUBLIC ABOUT THE COMPANY THROUGH SHERWOOD’S AFFILIATE RAGINGBULL.COM, LLC (“RAGING BULL”), AMONG OTHERS. THIS ADVERTISEMENT IS PART OF THOSE ISSUER-PAID MARKETING SERVICES. FOR DETAILED COMPENSATION AND MORE INFORMATION, PLEASE SEE THE FULL DISCLOSURE LOCATED AT HTTPS://BOARDROOMINVESTING.COM/MYMD-DISCLAIMER. DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of [RagingBull.com](, LLC are paid in whole or in part by commission based on their sales of Services to subscribers. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [Manage your email subscriptions.](